BLS Pharmaceuticals Limited · ASX:BLS
BLS Pharmaceuticals — Bioxyne — Investor Presentation (March 2018)
30 slides from BLS Pharmaceuticals's investor presentation, March 2018
Slide 1: Investor update
Investor update ASX: BXN March 2018
Slide 2: Disclaimer
Disdaimer All currency amounts are in A$ unless otherwise stated. This presentation has been prepared by Bioxyne Limited (“Company”). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not
Slide 3: Investment highlights
Investment highlights Bioxyne Limited (ASX: BXN) is a fast-growing Australian listed company, selling functional foods and probiotics into Asia Pacific markets Quality, dairy-based products, developed in Australia and New Zealand Foundation channel laid through PCC® ingredient sales to Chr. Hansen a
Slide 4: Our mission: bringing science to wellbeing
Our mission: bringing science to wellbeing
Slide 5: Quality products and ingredients
Quality products and ingredients Bioxyne International
Slide 6: Multi-channel growth strategy
Multi-channel growth strategy Direct sales channel – China and South East Asia PCC® Ingredient sales to Chr. Hansen & Nuskin Affiliate sales and marketing – Australia
Slide 7: Bioxyne's consumer health and beauty products
Bioxyne’s consumer health and beauty products
Slide 8: BK18 Dairy Based Food Supplement
BK18 Dairy Based Food Supplement www.bioxyne.com.my
Slide 9: Allura – Weight Management for Women
Allura – Weight Management for Women www.Bioxyne.com.my www.bioxyne.com.my
Slide 10: www.Bioxyne.com.my
www.Bioxyne.com.my
Slide 11: Mymana
my Med stim mile wilh colostrum & honey a i is Made in New Zealand from local and imported ingredients : Mymana Mymana is a unique colostrum Elare! honey based dairy formula product Daily consumption supports a healthy immune system with sustained energy and wellbeing for the entire family. www.biox
Slide 12: BEssence
BEssence www.bioxyne.com.my
Slide 13: Progastrim for gut and immune health
Progastrim® for gut and immune health Progastrim® www.Bioxyne.com www.bioxyne.com
Slide 14: PCC - Bioxyne's patented probiotic strain
PCC® - Bioxyne’s patented probiotic strain proTract® for Atopic Dermatitis protract® - For Infants with eczema Relieves symptoms of moderate to severe eczema in infants. Supports a healthy immune system www.bioxyne.com
Slide 15: Direct sales: Malaysian operations start – Nov 17
Direct sales: Malaysian operations start – Nov 17
Slide 16: Malaysian launch of men's health product, Mustang
Malaysian launch of men’s health product, Mustang Mustang, Bioxyne International's weight management and vitality product for men launched on 28 January 2018 into Malaysian market
Slide 17: Strong interest in Mustang from launch event
Strong interest in Mustang from launch event Launch drives conversion of initial reseller agreements
Slide 18: Setting up for growth – Direct Sales into SE Asia
Setting up for growth – Direct Sales into SE Asia Taiwan China Vietnam 2017 – key developments Malaysia ✓ Indonesia ✓ Australia New Zealand
Slide 19: Australian affiliate sales commenced – Oct 2017
Australian affiliate sales commenced – Oct 2017
Slide 20: Affiliate / influencer strategy
Affiliate / influencer strategy Building an army of influencers who are invested in the clinical benefits of Progastrim® and proTract®:
Slide 21: PCC Ingredient sales
PCC® Ingredient sales PCC® is the active ingredient in existing products distributed ProBio" globally Active ingredient manufactured PURE! SB; by industry leader Products manufactured and distributed in USA and Europe via key industry relationships ) = SYNBIOTICS HHHHH 8 i Pie sy
Slide 22: PCC is effective in boosting human health
PCC® is effective in boosting human health ✓ ✓ ✓ ✓ ✓
Slide 23: PCC patents
PCC® patents Title Territory Patent no. Status Priority Date Lactobacillus fermentum
Slide 24: Corporate overview
Corporate overview Top 10 shareholders Market data Rank Holder name % ASX ticker Market cap Shares on issue Performance rights for CEO Performance rights in Trust for distributors Annual revenues Cash reserves
Slide 25: Share price performance – Nov – Mar 18
Share price performance – Nov – Mar 18
Slide 26: Experienced leadership team
Experienced leadership team Tony Ho: Non-Executive Chairman. NH Chua: Managing Director. Patrick Ford: Non-Executive Director Max Parkin: Executive Director Guy Robertson: Company Secretary/CFO
Slide 27: Comparables
Comparables A2 Bellamy’s Wattle Bubs Bioxyne Health Exchange / A2M BAL WHA BUB BXN ticker Market cap $6 billion $2 billion $224 million $354 million $57.6 million Revenue A$337 $240 million $621k (1/2 $3.2 million $770k (1/2 million year) (1/2 year) year) Profit $52 million $35 million -$4 million -
Slide 28: Life-Space – January 2018 Chinese Acquisition
Life-Space – January 2018 Chinese Acquisition
Slide 29: Investment summary
Investment summary High growth Australian listed company, selling functional foods and probiotics into Asia Pacific markets Quality, dairy-based products, developed in Australia and New Zealand Foundation channel laid through PCC® ingredient sales to Chr. Hansen and Nuskin with around $2 million in
Slide 30: Bringing Science to Wellbeing
Contacts: N.H. Chua – Chief Executive Officer + 603 7931 9892 Anthony Ho – Non-Executive Chairman + 61 2 9078 8180 Bringing Science to Wellbeing Corporate Office: Suite 506 Level 5, 50 Clarence Street, Sydney NSW 2000 T : +61 2 9078 8180 E : info@bioxyne.com W : www.bioxyne.com